Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Luigia Vetrone"'
Autor:
Matteo Droghetti, Lorenzo Bianchi, Massimiliano Presutti, Luigia Vetrone, Andrea Farolfi, Riccardo Mei, Francesca Giunchi, Alessio Degiovanni, Angelo Mottaran, Pietro Piazza, Danilo Cangemi, Paolo Castellucci, Antonietta D’Errico, Riccardo Schiavina, Eugenio Brunocilla, Stefano Fanti
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionProstate-specific membrane antigen (PSMA) is a transmembrane protein expressed by normal prostatic tissue. Therefore, molecular imaging targeting PSMA (PSMA-PET) has gained particular interest and diffusion for PCa staging and restaging.
Externí odkaz:
https://doaj.org/article/e29ef3b516754b309a3bb765414b3300
Autor:
Luigia Vetrone, Giulia Cuzzani, Riccardo Mei, Lucia Zanoni, Alessandro Bertaccini, Lorenzo Bianchi, Paolo Castellucci, Caterina Gaudiano, Alberta Cappelli, Francesca Giunchi, Stefano Fanti
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
This is a case of [68 Ga]Ga-Prostate-specific membrane antigen (PSMA)-11 PET/CT in a 73-years old patient presenting high Prostate Specific Antigen (PSA) levels despite both multi-parametric magnetic resonance imaging (mpMRI) and 12-core saturation b
Externí odkaz:
https://doaj.org/article/af298609877c47ec8741ca9fd834136d
Autor:
Luigia Vetrone, Riccardo Mei, Lorenzo Bianchi, Francesca Giunchi, Andrea Farolfi, Paolo Castellucci, Matteo Droghetti, Massimiliano Presutti, Alessio Degiovanni, Riccardo Schiavina, Eugenio Brunocilla, Antonietta D’Errico, Stefano Fanti
Publikováno v:
Cancers, Vol 15, Iss 6, p 1716 (2023)
PSMA-PET/CT is a suitable replacement for conventional imaging in the primary staging of PCa. The aim of this retrospective study was to assess the correlation between parameters discovered by PSMA PET/CT in primary staging and either prostate histop
Externí odkaz:
https://doaj.org/article/de7c7b886f5d435cbda0e8d52b554f0b
Autor:
Alessandra Colapinto, Cristina Basso, Valentina Vicennati, Stefano Fanti, Elena Tabacchi, Arber Golemi, Letizia Calderoni, Luigia Vetrone, Rizzini Elisa Lodi, Margherita Nannini, Biase Dario De, GIovanni Tallini, Uberto Pagotto, Andrea Repaci
Publikováno v:
Endocrine Abstracts.
Autor:
Federico Zagni, Sara Vichi, Giulia Paolani, Miriam Santoro, Giuseppe Della Gala, Silvia Strolin, Paolo Castellucci, Luigia Vetrone, Stefano Fanti, Alessio Giuseppe Morganti, Lidia Strigari
Publikováno v:
Medical Physics.
Autor:
Luigia Vetrone, Rossella Caiazzo, Daniela Musio, Francesco Marampon, Vincenzo Tombolini, Francesca De Felice, Nadia Bulzonetti
Publikováno v:
Medical oncology (Northwood, London, England). 36(8)
This study was designed to evaluate the objective response after hypofractionated radiotherapy (HFRT) combined with cetuximab (HFBRT) in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma (HNSCC). Vulnerable elder